BR112013003675A2 - compostos com atividade anticteriana contra clostridium - Google Patents

compostos com atividade anticteriana contra clostridium

Info

Publication number
BR112013003675A2
BR112013003675A2 BR112013003675A BR112013003675A BR112013003675A2 BR 112013003675 A2 BR112013003675 A2 BR 112013003675A2 BR 112013003675 A BR112013003675 A BR 112013003675A BR 112013003675 A BR112013003675 A BR 112013003675A BR 112013003675 A2 BR112013003675 A2 BR 112013003675A2
Authority
BR
Brazil
Prior art keywords
compounds
activity against
anticterial
against clostridium
clostridium
Prior art date
Application number
BR112013003675A
Other languages
English (en)
Other versions
BR112013003675A8 (pt
Inventor
Jérôme Emile Georges Guillemont
Nacer Lounis
Pierre Jean-Marie Bernard Raboisson
Original Assignee
Elanco Animal Health Ireland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Elanco Animal Health Ireland filed Critical Elanco Animal Health Ireland
Publication of BR112013003675A2 publication Critical patent/BR112013003675A2/pt
Publication of BR112013003675A8 publication Critical patent/BR112013003675A8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

compostos com atividade anticteriana contra clostridium. a presente invenção refere-se a novos compostos da fórmula (i) tendo atividade antibacteriana contra bactérias clostridium, em particular, clostidrium perfringens, composições farmacêuticas compreendendo esses compostos, e processos químicos para a preparação desses compostos.
BR112013003675A 2010-08-04 2011-08-04 compostos com atividade antibacteriana contra clostridium BR112013003675A8 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP10171842 2010-08-04
PCT/EP2011/063434 WO2012017030A1 (en) 2010-08-04 2011-08-04 Compounds with antibacterial activity against clostridium

Publications (2)

Publication Number Publication Date
BR112013003675A2 true BR112013003675A2 (pt) 2016-09-06
BR112013003675A8 BR112013003675A8 (pt) 2017-12-26

Family

ID=43125618

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112013003675A BR112013003675A8 (pt) 2010-08-04 2011-08-04 compostos com atividade antibacteriana contra clostridium

Country Status (28)

Country Link
US (1) US8618100B2 (pt)
EP (1) EP2601193B1 (pt)
JP (1) JP5886285B2 (pt)
KR (1) KR101499368B1 (pt)
CN (1) CN103038234B (pt)
AR (1) AR082472A1 (pt)
AU (1) AU2011287584B2 (pt)
BR (1) BR112013003675A8 (pt)
CA (1) CA2805358C (pt)
CL (1) CL2013000331A1 (pt)
CO (1) CO6680629A2 (pt)
CY (1) CY1116238T1 (pt)
DK (1) DK2601193T3 (pt)
EA (1) EA021567B1 (pt)
ES (1) ES2538998T3 (pt)
HK (1) HK1180690A1 (pt)
HR (1) HRP20150467T1 (pt)
ME (1) ME02061B (pt)
MX (1) MX2013001246A (pt)
NZ (1) NZ605850A (pt)
PL (1) PL2601193T3 (pt)
PT (1) PT2601193E (pt)
RS (1) RS53990B1 (pt)
SG (1) SG187175A1 (pt)
SI (1) SI2601193T1 (pt)
TW (1) TWI498330B (pt)
WO (1) WO2012017030A1 (pt)
ZA (1) ZA201300432B (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9079935B2 (en) 2012-08-13 2015-07-14 The Board Of Regents Of The Nevada System Of Higher Education On Behalf Of The University Of Nevada, Las Vegas Reducing risk of contracting Clostridium-difficile associated disease
WO2016127102A2 (en) * 2015-02-06 2016-08-11 Ernesto Abel-Santos Inhibiting germination of clostridium perfringens spores to reduce necrotic enteritis
GB201509326D0 (en) 2015-05-29 2015-07-15 Antibio Tx Aps Novel use
KR101769204B1 (ko) * 2015-08-04 2017-08-17 씨제이헬스케어 주식회사 크로마놀 유도체의 신규한 제조방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2429289T3 (es) 2006-09-26 2013-11-14 Crestone, Inc. Compuestos enantioméricos con actividad antibacteriana
WO2008039642A2 (en) * 2006-09-26 2008-04-03 Replidyne, Inc. Methods and compounds for treatment of clostridium based infection
WO2008039639A2 (en) * 2006-09-26 2008-04-03 Crestone, Inc. Substituted thienopyridone compounds with antibacterial activity

Also Published As

Publication number Publication date
PL2601193T3 (pl) 2015-08-31
EP2601193B1 (en) 2015-03-11
US8618100B2 (en) 2013-12-31
EA201270817A1 (ru) 2013-05-30
JP5886285B2 (ja) 2016-03-16
CL2013000331A1 (es) 2013-06-28
BR112013003675A8 (pt) 2017-12-26
CA2805358A1 (en) 2012-02-09
ZA201300432B (en) 2014-08-27
SG187175A1 (en) 2013-02-28
EP2601193A1 (en) 2013-06-12
KR101499368B1 (ko) 2015-03-05
CO6680629A2 (es) 2013-05-31
TW201211048A (en) 2012-03-16
CY1116238T1 (el) 2017-02-08
SI2601193T1 (sl) 2015-05-29
TWI498330B (zh) 2015-09-01
WO2012017030A1 (en) 2012-02-09
US20130109694A1 (en) 2013-05-02
PT2601193E (pt) 2015-05-18
CN103038234B (zh) 2016-02-24
RS53990B1 (en) 2015-10-30
DK2601193T3 (en) 2015-03-23
KR20130033440A (ko) 2013-04-03
NZ605850A (en) 2014-07-25
EA021567B1 (ru) 2015-07-30
ES2538998T3 (es) 2015-06-25
HRP20150467T1 (hr) 2015-06-05
JP2013532714A (ja) 2013-08-19
AR082472A1 (es) 2012-12-12
AU2011287584A1 (en) 2013-02-07
HK1180690A1 (en) 2013-10-25
CA2805358C (en) 2016-02-16
MX2013001246A (es) 2013-03-21
AU2011287584B2 (en) 2014-05-01
ME02061B (me) 2015-05-20
CN103038234A (zh) 2013-04-10

Similar Documents

Publication Publication Date Title
MX2011005934A (es) Compuestos organicos.
MA33939B1 (fr) 5-alcynyl-pyrimidines
BRPI0922220B8 (pt) uso de compostos antibacterianos, composição farmacêutica e combinação compreendendo os mesmos
PH12014501967B1 (en) Benzodioxanes in combination with other actives for inhibiting leukotriene production
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
BR112013000107A2 (pt) aminopirazoloquinazolinas
BR112015009460A2 (pt) compostos 2-cefem substituídos
MY183312A (en) Pharmaceutical formulation
MY195343A (en) A Novel Phtalazinone Derivatives and Manufacturing Process Thereof
BR112014002958A2 (pt) "3,4-di-hidro-1h-[1,8]naftiridinonas substituídas com piperidinila antibacterianas, composição farmacêutica compreendendo os referidos compostos, processos para preparação destes e uso".
MX2015003021A (es) Derivados de acido glicirretinico y metodos de uso de los mismos.
BR112012032248A2 (pt) composições de 5-etil-2-{4-[-4(-4-tetrazol-1-il-fenoximetil)-tiazol-2-il]-piperidin-1-il}-pirimidina
BR112012007798A2 (pt) microcápsulas estáveis e composição para aplicação tópica e método para a preparação de microcápsulas
BR112012017393A2 (pt) derivados de 2,5,7-oxazolpirimidina substituída
BR112013004988A2 (pt) método para preparação de um composto
BR112013003675A8 (pt) compostos com atividade antibacteriana contra clostridium
MX367309B (es) Nuevos compuestos antibacterianos.
BR112012019920A2 (pt) derivados de piridazina úteis como agonístas de canabinoide-2.
MX363480B (es) Compuestos bacterianos que constan de un grupo heterocicloalquilo basado en nitrógeno que contiene un doble enlace unido a carbonilo que inhiben la enzima fabi.
MX2012004087A (es) Sulfonamidas para la prevencion de diabetes.
BR112012008649A2 (pt) Composição farmacêutica e usos da referida composição
BR112012012905A2 (pt) derivados de difenil azepina como inibidores da reabsorção de monoamina
BR112015014145A2 (pt) compostos antibacterianos
TR201010859A2 (tr) Sefdinir içeren tablet formları.
UA38601U (en) 2,2'-dithioxo-4,4'-dioxo-[5,5']-bithiazolidinyl-idene-diyl-3,3'-dibutanoic acid diarylamides having antitumor activity

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2473 DE 29-05-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.